Key Players
Competitive Landscape
Bakery protease programs draw three business models into the same technical account: enzyme specialists, diversified bioscience groups and bakery formulation companies with application laboratories. Industrial bakeries distinguish them by evidence on dough response and plant-trial access, then by how fast local teams convert flour variation into a stable specification.
Capital deployment began shifting toward local bakery testing in October 2025, when dsm-firmenich opened its Van Marken Food Innovation Center in Delft with dedicated bakery facilities. Kerry extended that regional model in February 2026 by opening its Medellín Customer Co-Creation Center with a bakery and confectionery laboratory. Industrial bakeries now compare trial access and response time beside the written enzyme specification during supplier qualification.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| In May 2026, AB Enzymes expanded distribution for food and baking applications in Mexico, Central America and the Caribbean. | Regional plants need quicker access to formulation support during qualification. | Enzyme companies are assigning food and baking portfolios to specialist local distributors. | Local technical channels can convert smaller regional accounts that do not support direct application teams. |
| In February 2026, IFF filed its 2025 Form 10-K with bakery inside Food Biosciences and enzymes among core technology categories. | Large bakery groups prefer vendors with documented regulated operations and broad food-bioscience resources. | Bakery enzyme activity is being managed inside larger bioscience platforms with global compliance infrastructure. | Broad platforms can cross-sell bakery enzyme work into customers already buying fermentation or food-bioscience technologies. |
| In July 2025, Lallemand acquired enzyme specialist Solyve and expanded its food-enzyme manufacturing platform. | Improver formulators want fewer technical handoffs between enzyme development and bakery application support. | Acquisitions are bringing enzyme production closer to existing baking-solution businesses. | Integrated fermentation and bakery teams can sell formulation support to millers, improver companies and industrial bakeries. |
Novonesis, Corbion and Puratos remain relevant outside the development table through bakery enzyme, formulation and flour-performance platforms used by industrial food manufacturers.
Source: Future Market Insights, Bakery Proteases Market and Bakery Enzymes Market Reports, 2026-2036.
The mapped companies collectively cover enzyme development, flour testing, bakery formulation work, regulatory documentation and regional application service.
Who leads the bakery proteases market?
Novonesis, IFF and Kerry show the broadest documented bakery-enzyme platforms among the mapped companies, while AB Enzymes has the clearest dedicated baking-laboratory specialization.
Which suppliers have documented qualification or quality approvals?
AB Enzymes has current FDA GRAS records for baking-related enzymes, while IFF documents bakery within its SEC-filed Food Biosciences business and regulated enzyme portfolio.
Which companies provide bread and dough application products?
AB Enzymes, Kerry, Puratos, Corbion and Lallemand document direct bakery application support, while Novonesis, IFF and dsm-firmenich provide broader enzyme or bioscience platforms.
Which suppliers serve North America and Europe?
Novonesis, IFF, Kerry, Puratos, Corbion, dsm-firmenich and Lallemand maintain multinational operations, while AB Enzymes pairs global coverage with regional baking laboratories and distributors.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Novonesis | Global biosolutions group with baking represented inside its Food & Beverages platform. | In June 2025, Novonesis launched Optiva LS Prime as a baking enzyme for reducing added sugar while retaining sweetness in commercial baked goods. |
| IFF | Global food-biosciences group with bakery included in Food Biosciences and enzymes among core technology categories. | In February 2026, IFF filed its 2025 Form 10-K and retained bakery inside Food Biosciences within its Health & Biosciences segment. |
| Kerry Group | Global taste and nutrition company with enzyme science and bakery application laboratories. | In February 2026, Kerry opened its Medellín Customer Co-Creation Center with dedicated bakery and confectionery laboratory space. |
| AB Enzymes | Enzyme specialist with dedicated baking laboratories and direct flour-milling support. | In May 2026, AB Enzymes expanded its distribution network for food, baking and flour-milling applications in Mexico, Central America and the Caribbean. |
| Puratos | Bakery formulation group with flour analytics, improvers and customer application infrastructure. Protease relevance is indirect in the verified action. | In August 2025, Puratos announced new Innovation Centers in Montreal and Cartago for bakery, patisserie and chocolate application work. |
| Corbion | Edge-of-scope bakery preservation and formulation participant. The verified action concerns icing reformulation instead of protease supply. | In June 2026, Corbion launched LUMI Set for commercial bakers reformulating water-based icings away from titanium dioxide. |
| dsm-firmenich | Global taste and texture group with enzyme and bakery application capabilities inside its wider food-technology platform. | In October 2025, dsm-firmenich opened the Van Marken Food Innovation Center in Delft with advanced bakery facilities. |
| Lallemand | Fermentation company with bakery solutions and an expanding food-enzyme manufacturing platform. | In July 2025, Lallemand acquired enzyme specialist Solyve and added its Normandy solid-state fermentation facility to the food-enzyme business. |
Research Methodology
The companies mapped here illustrate the bakery proteases market structure rather than an exhaustive supplier ranking. Inclusion requires current verifiable evidence that a company supplies baking enzymes, protease-relevant dough-conditioning systems or flour-performance application support within the defined bakery proteases scope. Evidence comes from regulatory approvals and third-party certifications as well as company announcements, product documentation and public filings. Capabilities are attributed to the documented baking enzyme platform, food-bioscience unit or bakery application laboratory rather than generalized across broader corporate portfolios. Market-share estimates remain proprietary FMI assessments prepared for the bakery proteases market during forecast period.
